Product Code: ETC4877021 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Nuclear Medicine Radioisotopes Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Hong Kong Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Hong Kong Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in Hong Kong leading to higher demand for nuclear medicine radioisotopes |
4.2.2 Technological advancements in nuclear medicine imaging techniques driving the market growth |
4.2.3 Rising investments in healthcare infrastructure and facilities in Hong Kong |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for nuclear medicine radioisotopes |
4.3.2 High costs associated with the production and procurement of radioisotopes |
4.3.3 Limited availability of skilled professionals in the field of nuclear medicine in Hong Kong |
5 Hong Kong Nuclear Medicine Radioisotopes Market Trends |
6 Hong Kong Nuclear Medicine Radioisotopes Market Segmentations |
6.1 Hong Kong Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021-2031F |
6.1.3 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021-2031F |
6.1.4 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021-2031F |
6.1.5 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021-2031F |
6.1.6 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021-2031F |
6.1.7 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021-2031F |
6.1.9 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.2 Hong Kong Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021-2031F |
6.2.4 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021-2031F |
6.2.5 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021-2031F |
6.2.6 Hong Kong Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
7 Hong Kong Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Hong Kong Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Hong Kong Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Hong Kong Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Hong Kong |
8.2 Adoption rate of advanced nuclear medicine imaging technologies in healthcare institutions |
8.3 Number of research and development collaborations in the field of nuclear medicine in Hong Kong |
9 Hong Kong Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Hong Kong Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Hong Kong Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Hong Kong Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Hong Kong Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |